June 15, 2021
Business News

Scott+Scott Attorneys at Law LLP Continues to Investigate Regeneron Pharmaceuticals, Inc.’s Directors and Officers for Breach of Fiduciary Duty (REGN)


NEW YORK–()–Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a national securities and consumer rights litigation firm, continues to investigate whether certain directors and officers of Regeneron Pharmaceuticals, Inc. (“Regeneron”) (NASDAQ: REGN) breached their fiduciary duties to Regeneron and its shareholders. If you are a Regeneron shareholder, you are encouraged to contact attorney Joe Pettigrew toll-free at (844) 818-6982 or [email protected].

Scott+Scott is investigating whether Regeneron’s board of directors or senior management failed to manage Regeneron in an acceptable manner, in breach of their fiduciary duties to Regeneron, and whether Regeneron has suffered damages as a…



Click here to view the original article.

Related Posts

You might also like ...

Carbios Awarded as Technology Pioneer by World Economic Forum
AON Splash Image
G2 Venture Partners Closes New Fund With $500 Million to Drive the Next Stage of Sustainable Transformation in Traditional Industries
Heliogen Raises $108 Million to Advance New Non-Intermittent Renewable Energy Technology for Heat, Power, and Green Hydrogen